R.Soliman, A., F. M. Bolis, and K. M. Sadek, "Pathological Features of Recovery or Progression in Acute Tubular Necrosis: Single Centre Study", Saudi Journal of Kidney diseases and Transplantation, vol. 33, pp. :S12-S17 , 2022.
application/pdf iconpathological_features_of_recovery_or_progression_in_acute_tubular.pdf
Momtaz, M., A. Fayed, K. Marzouk, and A. Shaker, "Therapeutic Plasma Exchange Outcomes in Cairo University Hospitals: 6 Years Experience.", Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, vol. 22, issue 6, pp. 666-673, 2018 Dec. Abstract

Therapeutic plasma exchange is used in treating different immunological and non-immunological diseases. We analyzed the outcome of 308 patients treated by 1783 membrane plasma exchange sessions from January 2011 until January 2017 at Cairo University Hospital. Thrombotic microangiopathies were the commonest indication [73 (23.7%) patients] with response in 63/73 patients (86.3%), followed by systemic vasculitis with pulmonary-renal involvement [40(13%) patients] with recovery in 32/40 patients (80.0%), Guillain-Barré syndrome [39(12.7%) patients] with recovery in 30/39 patients (76.9%), myasthenia gravis [31(10.1%) patients] with response in 26/31 patients (83.9%), and catastrophic antiphospholipid syndrome [28(9.1%) patients] with recovery in only 6/28 patients (21.4%). Complications included hypotension [276/1783 (15.5%) sessions], hypocalcemia [26/308 (8.5%) patients], and 37/308 (12%) patients died. Sepsis caused mortality in 29/37 (78.4%) of patients. In conclusion, our therapeutic plasma exchange experience shows a favorable outcome for thrombotic microangiopathies, systemic vasculitis, myasthenia gravis, and Guillain-Barré syndrome. Sepsis was the leading mortality cause.

Tourism